Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-01-27 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser makes provisions due to retroactive "payback" levy | Pressreleaser | Visa Stäng |
|
||||
2023-01-27 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser gör reservering på grund av retroaktiv "payback"-avgift | Pressreleaser | Visa Stäng |
|
||||
2022-12-02 | Penser Access | Penser Access: Lockande läge inför 2023 - Devyser | Analyser | Visa Stäng |
|
||||
2022-11-15 | Analysguiden | Analysguiden: ANALYS Devyser: Stabilt kvartal och många pusselbitar faller på plats | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-15 | Penser Access | Penser Access: Intervju med Devyser - Erik Penser Bank - 15 nov 2022 | Analyser | Visa Stäng |
|
||||
2022-11-11 | Redeye | Redeye: Devyser Q3 - Solid performance and strong gross margin | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-10 | Pinpoint Estimates | Pinpoint Estimates: Devyser Diagnostics rapport i linje med Pinpointkonsensus | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-10 | Devyser Diagnostics | Devyser Diagnostics AB publishes Interim Report for the period, January to September 2022 | Rapporter | Ladda ner | Visa Stäng |
Rapporter |
Devyser Diagnostics AB publishes Interim Report for the period, January to September 2022”Devyser reports yet another quarter of record sales and strong gross margins. The positive sales and margin trend remains stable. We are following the strategic plan we launched nearly two years ago. It involves converting to direct sales in certain markets where we are currently working with distributors, and increasing our focus on selected key markets, including the important North American market. So far, we have managed to exceed the plan’s high expectations on sales growth and margins.” Fredrik Alpsten, CEO, Devyser Quarter July-September 2022
The period from January to September 2022
Important events during the quarter Certification under the new European IVD Regulation In August, Devyser was certified under the new, more comprehensive IVD Regulation, which came into force on May 26, 2022. The regulation ensures the highest level of clinical safety for the manufacture of medical devices. The certification covers Devyser’s quality management system and fetal diagnostics product. Strengthening of the management team In September, Camilla Wiberg took up the position of CHRO (Chief Human Resources Officer). Following Camilla Wiberg’s appointment, Devyser’s senior management consists of CEO Fredrik Alpsten, CFO Sabina Berlin, CCO Theis Kipling, COO Göran Rydin, CHRO Camilla Wiberg and Deputy CEO Ulf Klangby. New share issues In July, 63,900 shares were issued in connection with the exercising of warrants. The new issue raised SEK 0.8 million for the company. Following the issue, the number of Devyser shares totaled 16,006,369. Important events after the end of the quarter Establishes CLIA lab in USA Adding to the company’s current business model, Devyser will establish a CLIA laboratory in Atlanta, Georgia, USA. CLIA, Clinical Laboratory Improvement Amendments, is an opportunity that enables Devyser to offer test services directly to its US customers. The company aims to have the lab CLIA-certified and operational in the second quarter 2023. The report is available on the company’s webpage: https://investors.devyser.com/en/reports-presentations This information is information that Devyser Diagnostics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication, through the agency of the contact persons below, on November 10, 2022 at 07:30 CET. For more information, please contact: Fredrik Alpsten, CEO Sabina Berlin, CFO About Devyser Diagnostics AB (publ) Devyser develops, produces, and commercializes genetic test kits for laboratories in more than 45 countries. The products are used for advanced DNA testing within hereditary diseases, oncology, and transplantation to guide targeted cancer therapies, diagnose a wide array of genetic diseases, and to assist in post-transplant follow-up. Devyser’s products simplify complex genetic testing processes, minimize hands-on time and deliver rapid, accurate, and trusted results. Devyser was founded in 2004 and is based in Stockholm, Sweden. Devyser’s shares are listed on Nasdaq First North Growth Market (ticker: DVYSR).The company’s Certified Adviser is Redeye AB. For more information, visit www.devyser.com. |
||||
2022-11-10 | Devyser Diagnostics | Devyser Diagnostics AB publicerar delårsrapport för januari till september 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-09 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser strengthens its presence on the US market - establishes proprietary CLIA lab | Pressreleaser | Visa Stäng |
|
||||
2022-11-09 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser stärker sin närvaro i USA - öppnar eget CLIA-laboratorium | Pressreleaser | Visa Stäng |
|
||||
2022-11-08 | Penser Access | Penser Access: Tillväxt i sitt DNA - Devyser | Analyser | Visa Stäng |
|
||||
2022-11-02 | Devyser Diagnostics | Devyser Diagnostics AB: Inbjudan till audiocast för Devysers Q3-rapport 2022 | Pressreleaser | Visa Stäng |
|
||||
2022-11-02 | Devyser Diagnostics | Devyser Diagnostics AB: Invitation to audiocast for Devyser's Q3 Report 2022 | Pressreleaser | Visa Stäng |
|
||||
2022-11-01 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser appoints John Murad as General Manager in the US | Pressreleaser | Visa Stäng |
|
||||
2022-11-01 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser utser John Murad till General Manager i USA | Pressreleaser | Visa Stäng |
|
||||
2022-10-31 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser appoints Carnegie Investment Bank AB as liquidity provider | Pressreleaser | Visa Stäng |
|
||||
2022-10-31 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser utser Carnegie Investment Bank till likviditetsgarant | Pressreleaser | Visa Stäng |
|
||||
2022-08-29 | Devyser Diagnostics | Devyser Diagnostics AB: Devysers kvalitetsledningssystem och produkt för fosterdiagnostik godkända enligt nya europeiska IVDR-regelverket | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-29 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser's quality management system and fetal diagnostics product approved under the new European IVD Regulation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-29 | Redeye | Redeye: Devyser Q2 - Delivering well on its financial targets | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | Analysguiden | Analysguiden: ANALYS Devyser Diagnostics: Stark tillväxt och vinner viktig mark i Kanada | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-24 | Pinpoint Estimates | Pinpoint Estimates: Devyser Diagnostics nettoomsättning strax under Pinpointkonsensus | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-24 | Devyser Diagnostics | Devyser Diagnostics AB publicerar delårsrapport för januari till juni 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-08-24 | Devyser Diagnostics | Devyser Diagnostics AB publishes Interim Report for the period, January to June 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-08-18 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser appoints Camilla Wiberg as Chief HR Officer | Pressreleaser | Visa Stäng |
|
||||
2022-08-18 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser utser Camilla Wiberg till Chief HR Officer | Pressreleaser | Visa Stäng |
|
||||
2022-08-17 | Pinpoint Estimates | Pinpoint Estimates: Devyser Diagnostics inleder samarbete med estimattjänsten Pinpoint Estimates | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-17 | Devyser Diagnostics | Devyser Diagnostics AB: Inbjudan till audiocast för Devysers Q2-rapport 2022 | Pressreleaser | Visa Stäng |
|
||||
2022-08-17 | Devyser Diagnostics | Devyser Diagnostics AB: Invitation to audiocast for Devyser's Q2 Report 2022 | Pressreleaser | Visa Stäng |
|
||||
2022-06-22 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser wins breakthrough contract in Canada for non-invasive fetal RHD testing | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-06-22 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser vinner genombrottskontrakt i Kanada för icke-invasiv RHD-testning av foster | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-06-07 | Analysguiden | Analysguiden: INITIERINGSANALYS DEVYSER DIAGNOSTICS: Snabbväxare inom gentest med skyhöga marginaler | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-05-12 | Redeye | Redeye: Devyser - A Strong Start to 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-05-11 | Devyser Diagnostics | Kommuniké från årsstämma i Devyser Diagnostics AB (publ) den 11 maj 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-05-11 | Devyser Diagnostics | Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 11 May 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-05-11 | Devyser Diagnostics | Devyser Diagnostics AB: Record sales and increased gross margin for Devyser | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-05-11 | Devyser Diagnostics | Devyser Diagnostics AB: Rekordförsäljning och ökad bruttomarginal för Devyser | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-05-10 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser presenterar på Aktiedagen Göteborg den 16 maj | Pressreleaser | Visa Stäng |
|
||||
2022-05-02 | Devyser Diagnostics | Devyser Diagnostics AB: Inbjudan till audiocast för Devysers Q1-rapport 2022 | Pressreleaser | Visa Stäng |
|
||||
2022-05-02 | Devyser Diagnostics | Devyser Diagnostics AB: Invitation to audiocast for Devyser's Q1 Report 2022 | Pressreleaser | Visa Stäng |
|
||||
2022-04-13 | Devyser Diagnostics | Kallelse till årsstämma 2022 i Devyser Diagnostics AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-04-12 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser ökar kommersiellt fokus genom nyrekrytering till ledningsgruppen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-04-12 | Devyser Diagnostics | Devyser Diagnostics AB: New appointment to Devyser's management team enhances commercial focus | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-04-06 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser publishes annual report for 2021 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-04-06 | Devyser Diagnostics | Devyser Diagnostics AB: Devyser publicerar årsredovisning för 2021 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-04-06 | Redeye | Redeye: Redeye Initiates Coverage of Devyser | Analyser | Ladda ner | Visa Stäng |
|